Wetherby Asset Management Inc. reduced its stake in shares of Humana Inc (NYSE:HUM) by 1.1% during the first quarter, HoldingsChannel.com reports. The firm owned 4,250 shares of the insurance provider’s stock after selling 49 shares during the quarter. Wetherby Asset Management Inc.’s holdings in Humana were worth $1,131,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. We Are One Seven LLC purchased a new position in Humana during the 4th quarter valued at $31,000. Proficio Capital Partners LLC grew its position in shares of Humana by 81.4% in the 4th quarter. Proficio Capital Partners LLC now owns 107 shares of the insurance provider’s stock worth $31,000 after buying an additional 48 shares during the period. Destination Wealth Management grew its position in shares of Humana by 130.0% in the 1st quarter. Destination Wealth Management now owns 115 shares of the insurance provider’s stock worth $31,000 after buying an additional 65 shares during the period. Exane Asset Management purchased a new stake in shares of Humana in the 4th quarter worth about $43,000. Finally, Sontag Advisory LLC purchased a new stake in shares of Humana in the 4th quarter worth about $47,000. 90.27% of the stock is currently owned by institutional investors and hedge funds.
A number of analysts have recently weighed in on HUM shares. Credit Suisse Group reduced their target price on shares of Humana from $352.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, May 2nd. Citigroup reduced their target price on shares of Humana from $397.00 to $362.00 and set a “buy” rating on the stock in a research report on Thursday, February 7th. Barclays reduced their target price on shares of Humana from $351.00 to $327.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 17th. Oppenheimer reduced their target price on shares of Humana from $373.00 to $350.00 and set an “outperform” rating on the stock in a research report on Thursday, May 2nd. Finally, ValuEngine downgraded shares of Humana from a “hold” rating to a “sell” rating in a research report on Thursday, April 11th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have issued a buy rating to the company. Humana currently has a consensus rating of “Buy” and a consensus price target of $337.26.
In related news, insider Christopher H. Hunter sold 15,586 shares of the company’s stock in a transaction dated Monday, February 25th. The shares were sold at an average price of $305.24, for a total value of $4,757,470.64. Following the transaction, the insider now owns 28,100 shares in the company, valued at approximately $8,577,244. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.54% of the company’s stock.
Humana stock traded up $3.83 during mid-day trading on Friday, reaching $263.33. The stock had a trading volume of 2,333,283 shares, compared to its average volume of 1,362,280. The stock has a market cap of $34.67 billion, a price-to-earnings ratio of 18.10, a PEG ratio of 1.05 and a beta of 0.88. Humana Inc has a one year low of $225.65 and a one year high of $355.88. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.65 and a quick ratio of 1.65.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, May 1st. The insurance provider reported $4.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $4.30 by $0.18. The company had revenue of $16.11 billion for the quarter, compared to analysts’ expectations of $15.67 billion. Humana had a net margin of 2.99% and a return on equity of 20.77%. Humana’s revenue was up 12.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.36 EPS. On average, equities analysts expect that Humana Inc will post 17.57 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a yield of 0.84%. The ex-dividend date of this dividend is Thursday, June 27th. Humana’s payout ratio is 15.12%.
WARNING: “Humana Inc (HUM) Shares Sold by Wetherby Asset Management Inc.” was first posted by Zolmax and is the sole property of of Zolmax. If you are reading this news story on another website, it was illegally stolen and reposted in violation of US and international copyright laws. The legal version of this news story can be accessed at https://zolmax.com/investing/humana-inc-hum-shares-sold-by-wetherby-asset-management-inc/3095142.html.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.